These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
514 related items for PubMed ID: 17162272
1. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy. Cotiga D, Ehlert F, Sherrid M. Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272 [Abstract] [Full Text] [Related]
3. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L. Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196 [Abstract] [Full Text] [Related]
4. Sudden death and hypertrophic cardiomyopathy: a review. Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D. Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263 [Abstract] [Full Text] [Related]
5. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy]. Hentati M, Ben Ameur I, Kechida Z, Charfeddine H, Hached L, Grati Z, Kammoun S. Tunis Med; 2003 Apr; 81 Suppl 8():675-9. PubMed ID: 14608758 [Abstract] [Full Text] [Related]
9. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy]. Sadoul N, de Chillou C, Aliot E, McKenna WJ. Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160 [Abstract] [Full Text] [Related]
10. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. Maron BJ, Spirito P. J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577 [Abstract] [Full Text] [Related]
11. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM]. Maron BJ, Spirito P. Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):297-302. PubMed ID: 19791462 [Abstract] [Full Text] [Related]
16. ST-segment depression as a risk factor in hypertrophic cardiomyopathy. Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA. Europace; 2009 May 18; 11(5):643-9. PubMed ID: 19164362 [Abstract] [Full Text] [Related]
17. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M. Am Heart J; 2007 Nov 18; 154(5):899-907. PubMed ID: 17967596 [Abstract] [Full Text] [Related]
19. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy]. Maron BJ. Rev Esp Cardiol; 2006 Jun 18; 59(6):527-30. PubMed ID: 16790193 [No Abstract] [Full Text] [Related]